Plasma NGAL levels were higher in patients with AKI compared to those without AKI; however, substantial inter-individual variability resulted in false-negative results in 56% of patients with AKI and false-positive results in 32% of patients without AKI. This evidence concerns the gene LCN2 and acute kidney injury.